Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Filings indexed 734 across all filing types
Latest filing 2025-02-18 Transaction in Own Shar…
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where the company purchased 789,529 of its ordinary shares into treasury on February 18, 2025. It details the volume, prices, and the resulting number of shares in issue and treasury. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The presence of the RNS Number and the closing statement confirming RNS as the information provider suggests it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2025-02-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where the company purchased 750,000 ordinary shares into treasury. This directly corresponds to the definition of a company buying back its own shares. The filing is identified by the RNS Number and the content matches the 'Transaction in Own Shares' category, which maps to the 'POS' filing type code.
2025-02-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states 'TRANSACTION IN OWN SHARES' and details the purchase of a specific number of ordinary shares (405,691) by the company into treasury, including the price range and the resulting total shares in issue. This directly corresponds to the definition of 'Transaction in Own Shares' (Share Repurchase/Issuance). The filing is marked with RNS Number, indicating it is a regulatory announcement, but the content is specific enough to map to POS.
2025-02-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where the company purchased a specific number of its ordinary shares into treasury. This directly corresponds to the definition of a company buying back or selling its own shares. The filing uses the RNS (Regulatory News Service) format, but the specific content maps precisely to the 'Transaction in Own Shares' category (POS). The document details the number of shares purchased, the price range, and the resulting treasury share balance and total voting rights.
2025-02-10 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where the company purchased a specific number of its ordinary shares into treasury on February 6, 2025. It details the volume, price, and the resulting number of shares in treasury and total shares in issue. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The presence of 'RNS Number' and the closing statement about RNS confirms it is a regulatory announcement, but the specific content dictates the classification.
2025-02-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'TRANSACTION IN OWN SHARES' where BioPharma Credit PLC purchased a specific number of its ordinary shares into treasury. This directly corresponds to the definition of a company buying back or selling its own shares. The filing uses the RNS system, but the content is highly specific to share repurchase activity, matching the 'Transaction in Own Shares' category (POS). The document length is short (2990 chars), but the content is the primary announcement itself, not an announcement *about* a report, thus it is not RPA or RNS.
2025-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.